KATHLEEN KURIT: Open Payments
NPI 1851473524 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 96 payments from 23 companies in 2025. Trend: 2023 $1,858 · 2024 $1,579 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $399 |
| SANOFI-AVENTIS U.S. LLC | 5 | $283 |
| Amgen Inc. | 12 | $271 |
| Lilly USA, LLC | 11 | $160 |
| Dexcom, Inc. | 9 | $138 |
| Mannkind Corporation | 6 | $131 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| ABBVIE INC. | 3 | $74 |
| BETA BIONICS, INC. | 3 | $66 |
| Sequel Med Tech, LLC | 3 | $63 |
Products named: TZIELD, Ozempic, EVENITY, Dexcom G6 Transmitter, AFREZZA, CRENESSITY, MOUNJARO, Wegovy.
Industry payments across FL — which companies pay providers there.
